Certificate of Achievement
has completed the following course:
Innovative Therapies and Personalised Medicine for Rare Diseases
Foundation for Rare Diseases and European Joint Programme on Rare Diseases
This course gives an overview of the last generation therapeutic treatments and approaches (e.g. gene therapy, protein-based approaches, regenerative medicine, cell therapy, transplants, tissue engineering), leveraging advancements in the fields of molecular biology and immunology. The significance of these personalized approaches in treating rare diseases is discussed, along with the challenges that still need to be resolved, from a scientific, and from an ethical and regulatory standpoint.
5 weeks, 4 hours per week
Magda Granata
European Joint Programme on Rare Diseases - WP16 Online Academic Course Coordinator
Foundation for Rare Diseases
Transcript
Learning outcomes
- Describe what is meant by rare diseases and illustrate the challenges related to the treatment of such a kind of diseases
- Explain what the most innovative approaches are for developing therapies, such as gene therapy, protein-based approaches, and cell therapy
- Describe what is meant by regenerative medicine and how cell therapy, tissue engineering and transplants contribute to this field
- Summarise why all these approaches are particularly relevant for rare diseases
- Debate what personalized medicine is and explain how it differs from the classical “one fits all approach”
- Describe the role of clinical data in developing innovative personalized treatments
- Describe how health data are optimally managed from the regulatory perspective
- Discuss the current real-world challenges related to the development of personalized treatments and how they could be overcome
Syllabus
*The challenges related to the treatment of rare diseases.
*The rationale behind most recent therapeutic approaches, such as gene therapy, protein-based therapies, regenerative medicine, cell therapy, tissue engineering, transplantation and their application in rare diseases.
*The importance of tailoring treatments for rare conditions, on the basis of the individual’s genetic make-up.
*The challenges involved in shifting the healthcare approach from one-size-fits-all to personalised methods.
In association with
Issued on 12th January 2026
The person named on this certificate has completed the activities in the transcript above. For more information about Certificates of Achievement and the effort required to become eligible, visit futurelearn.com/proof-of-learning/certificate-of-achievement.
This certificate represents proof of learning. It is not a formal qualification, degree, or part of a degree.